Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Incobotulinum toxin A for ultraviolet B-induced hyperpigmentation
TCTR20211111001Phase 3Completed
- Sponsor
- Ramathibodi Hospital
- Start
- Aug 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of incobotulinumtoxinA in Hyperpigmentation, sponsored by Ramathibodi Hospital. Started Aug 2021; status: completed.
02
Drugs
incobotulinumtoxinA
03
Conditions
Hyperpigmentation
Beyond the preview
Go deeper on TCTR20211111001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211111001.